Vident Advisory »

Summit Therapeutics shares owned by Vident Advisory

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Vident Advisory from 13F filings

Historical chart of Vident Advisory investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Vident Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Vident Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $757k 37k 20.66
2025-06-30 $833k 39k 21.28
2025-03-31 $794k 41k 19.29